Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease.
暂无分享,去创建一个
Anne Eckert | Walter E. Müller | A. Eckert | U. Keil | Celio A. Marques | Uta Keil | Katrin Schüssel | Astrid Bonert | Claudia Frey | K. Schüssel | A. Bonert | C. Frey | C. Marques | W. Müller
[1] G. Forloni,et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.
[2] M. Mattson,et al. Superoxide mediates the cell‐death‐enhancing action of presenilin‐1 mutations , 1999, Journal of neuroscience research.
[3] S. Leutner,et al. Effects of EGb 761® Ginkgo biloba Extract on Mitochondrial Function and Oxidative Stress , 2003, Pharmacopsychiatry.
[4] S. Rapoport,et al. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. , 1994, Brain research. Molecular brain research.
[5] C. Cotman,et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[7] M. Orth,et al. Mitochondria and degenerative disorders. , 2001, American journal of medical genetics.
[8] L. Pellegrini,et al. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death. , 1999, The Journal of biological chemistry.
[9] M. Greenberg,et al. β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand , 2001, The Journal of Neuroscience.
[10] D. Wallace. Mitochondrial DNA mutations in diseases of energy metabolism , 1994, Journal of bioenergetics and biomembranes.
[11] A. Leslie,et al. The rotary mechanism of ATP synthase. , 2000, Current Opinion in Structural Biology.
[12] N. Bresolin,et al. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. , 1999, Science.
[13] M. Mattson,et al. Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.
[14] Stanley I. Rapoport,et al. Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients , 1996, Brain Research.
[15] C. Cotman,et al. DNA Damage and Activated Caspase-3 Expression in Neurons and Astrocytes: Evidence for Apoptosis in Frontotemporal Dementia , 2000, Experimental Neurology.
[16] M. Hennerici,et al. Elevated Levels of Fragmented DNA Nucleosomes in Native and Activated Lymphocytes Indicate an Enhanced Sensitivity to Apoptosis in Sporadic Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.
[17] Gabriele Siciliano,et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease , 2002, Neurobiology of Aging.
[18] C. Culmsee,et al. Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases , 1999, Annals of the New York Academy of Sciences.
[19] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[20] J. B. Hutchins,et al. Bcl‐2 Protects Isolated Plasma and Mitochondrial Membranes Against Lipid Peroxidation Induced by Hydrogen Peroxide and Amyloid β‐Peptide , 1998, Journal of neurochemistry.
[21] M. Beal. Mitochondria, free radicals, and neurodegeneration , 1996, Current Opinion in Neurobiology.
[22] C. Haass,et al. Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation , 2003, Journal of Biological Chemistry.
[23] S. Kish,et al. Decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Disease and in Hereditary Spinocerebella Ataxia Disorders , 1999, Journal of neurochemistry.
[24] Robert B. Petersen,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[25] P. Mecocci,et al. Oxidative damage to DNA in lymphocytes from AD patients , 1998, Neurology.
[26] D. Wallace. Mitochondrial diseases in man and mouse. , 1999, Science.
[27] M. Mattson,et al. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders , 2002, NeuroMolecular Medicine.
[28] M. Smith,et al. Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.
[29] P Riederer,et al. Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress? , 1998, Annals of neurology.
[30] C. Bieberich,et al. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.
[31] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[32] L. Greene,et al. β‐Amyloid‐induced neuronal apoptosis requires c‐Jun N‐terminal kinase activation , 2001, Journal of neurochemistry.
[33] T. Hartmann,et al. Intracellular biology of Alzheimer’s disease amyloid beta peptide , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[34] M. Mattson,et al. β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .
[35] Miles W. Miller,et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice , 1999, Nature Medicine.
[36] Jason P. Sheehan,et al. Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[37] C. Luckhaus,et al. Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice , 2001, Neurobiology of Disease.
[38] M. Mattson,et al. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. , 2008, Journal of neurochemistry.
[39] J. Martinou,et al. Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.
[40] Guido Kroemer,et al. Mitochondrial control of cell death , 2000, Nature Medicine.
[41] J. Land,et al. β‐Amyloid inhibits integrated mitochondrial respiration and key enzyme activities , 2001, Journal of neurochemistry.
[42] D. Vaux,et al. A Cinderella Caspase Takes Center Stage , 2002, Science.
[43] Y. Christen,et al. Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.
[44] W. Müller,et al. β-amyloid peptide decreases membrane fluidity , 1995, Brain Research.
[45] G. Gibson. Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease. , 2002, Free radical biology & medicine.
[46] J. Parks,et al. Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro , 2001, Journal of neurochemistry.
[47] Guy C. Brown. NO Says Yes to Mitochondria , 2003, Science.
[48] G. Kroemer,et al. The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.
[49] J. Blass,et al. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. , 1991, Revue neurologique.
[50] K. Abe,et al. Both oxidative stress-dependent and independent effects of amyloid β protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay , 1999, Brain Research.
[51] J. Thome,et al. Advanced glycation endproducts in ageing and Alzheimer's disease , 1997, Brain Research Reviews.
[52] M. Mattson,et al. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.
[53] D. Harman. Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.
[54] George Perry,et al. Role of mitochondrial dysfunction in Alzheimer's disease , 2002, Journal of neuroscience research.
[55] J. Lee,et al. Amyloid-β Induces Smac Release via AP-1/Bim Activation in Cerebral Endothelial Cells , 2002, The Journal of Neuroscience.
[56] M. Beal,et al. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. , 2002, Human molecular genetics.
[57] C. Masters,et al. Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease , 1999, Annals of neurology.
[58] N. Cairns,et al. An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease , 1997, Journal of neurochemistry.
[59] C. Haass,et al. Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.
[60] N Howell,et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[61] T. Arendt,et al. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer’s disease , 2001, Brain Research.
[62] W. Tatton,et al. Mitochondrial Membrane Potential and Nuclear Changes in Apoptosis Caused by Serum and Nerve Growth Factor Withdrawal: Time Course and Modification by (؊)-deprenyl , 2022 .
[63] P. Riederer,et al. Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia. , 2001, Archives of gerontology and geriatrics.
[64] H. Möller,et al. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.
[65] John Calvin Reed,et al. Bcl-2 family proteins and mitochondria. , 1998, Biochimica et biophysica acta.
[66] M. Schapiro,et al. Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[67] G. Sobue,et al. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease , 2002, Acta Neuropathologica.
[68] B. Hyman,et al. Functional Alterations in Alzheimer's Disease: Selective Loss of Mitochondrial-encoded Cytochrome Oxidase mRNA in the Hippocampal Formation , 1994, Journal of neuropathology and experimental neurology.
[69] C. Czech,et al. Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms , 2000, Progress in Neurobiology.
[70] J. Blass,et al. The α-ketoglutarate dehydrogenase complex in neurodegeneration , 2000, Neurochemistry International.
[71] H. Wiśniewski,et al. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. , 1992, Biochemical and biophysical research communications.
[72] G. Gibson,et al. Differential alterations in antioxidant capacity in cells from Alzheimer patients. , 2000, Biochimica et biophysica acta.
[73] S. Budd,et al. Mitochondria and neuronal survival. , 2000, Physiological reviews.
[74] C. Cotman,et al. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. , 1991, European journal of pharmacology.
[75] M. Mattson,et al. Presenilin mutations and calcium signaling defects in the nervous and immune systems. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[76] Hsueh‐Meei Huang,et al. Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation. , 2003, Biochimica et biophysica acta.
[77] C. Cotman,et al. Up‐regulation of Bcl‐2 is associated with neuronal DNA damage in Alzheimer's disease , 1996, NeuroReport.
[78] C. Cotman,et al. Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.
[79] H. Chung,et al. The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain. , 2000, Biochemical and biophysical research communications.
[80] F. Sanger,et al. Sequence and organization of the human mitochondrial genome , 1981, Nature.
[81] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[82] Y. Ihara,et al. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. , 2000, Biochemistry.
[83] C. Cotman,et al. Enhanced vulnerability to apoptotic cell death in sporadic Alzheimer's disease , 1998, Neuroreport.
[84] J C Reed,et al. Mechanisms of apoptosis. , 2000, The American journal of pathology.
[85] William H. Nesse,et al. Activation of Caspase-8 in the Alzheimer's Disease Brain , 2001, Neurobiology of Disease.
[86] G. Cortopassi,et al. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.